stage ivb bladder cancer ajcc v8

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States

Recruiting
  • Bladder Adenocarcinoma
  • +45 more
  • Cabozantinib S-malate
  • +2 more
  • Birmingham, Alabama
  • +563 more
Aug 24, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +23 more
  • Riverside, California
  • +8 more
Jul 16, 2022

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

Recruiting
  • Bladder Small Cell Neuroendocrine Carcinoma
  • +16 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022

Bladder Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8, Stage IVA Bladder Cancer AJCC v8 Trial in Los Angeles

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Dec 2, 2021